Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
10 Demonstrated Systems to Develop Your Internet based Business - 2Ads promising cosmetic surgery patients a ‘dream body’ with minimal risk get little scrutiny
- 3Consumers advised to dispose of 19 cooking pans due to lead leaching risk, FDA reports
- 4Figure out How to Modify Your Pre-assembled Home for Greatest Solace and Stylish Allure
- 5Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- Auschwitz Committee wants German auction of Holocaust items scrapped
- Find Serenity: 10 Stunning Setting up camp Areas
- A definitive Frozen yogurt Standoff: Which Flavor Rules?
- 10 Natural products to Remember for Your Eating routine for a Better You
- Voting begins in Uganda’s presidential election during internet shutdown and polling station delays
- Linda Hamilton, 69, says she doesn't want to 'chase longevity'
- A company is trying to unlock a key to aging, in a long-overlooked body part
- 5 Language Learning Applications
- Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
